From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
Clinical Characteristics | JDM (n=13) | Adult DM (=10) | P value |
---|---|---|---|
MMT 80 median [IQR] | 78 [73-80] | 78 [67-80] | ns |
DAS skin median [IQR] | 2 [0.5-2] | 0.5 [0-2.5] | ns |
PGA median [IQR] | 0.8 [0-3.5] | 2 [0-7] | ns |
Presence of Calcinosis (%) | 7 (54%) | 2 (20%) | ns |
Arthritis (%) | 6 (48%) | 3 (30%) | ns |
Interstitial lung disease (ILD) (%) | 1 (8%) | 7 (70%) | p=0.002 |
ANA positivity (%) | 6 (46%) | 10 (100%) | p=0.02 |
CK U/L median [IQR] | 93 [70.5-668] | 46 [43-134] | ns |
Monotherapy/ Biologic agents with other DMARDs | 4 (31%)/3 (23%) | 3 (30%)/1 (10%) | ns/ ns |